Sun BioPharma Research, Inc. — Form D/A

Sun BioPharma Research, Inc. of Waconia, MN, a company, filed a Form D amendment with the SEC on 2013-06-28. The offering totals $2.3M, of which $2.3M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (22)

NameRoleLocation
Thomas X NeenanDirectorBoston, MA
Thomas X NeenanExecutive OfficerBoston, MA
D. ROBERT SCHEMELDirectorWACONIA, MN
Jeffrey R HarderDirectorHouston, TX
Paul W SchafferDirectorWaconia, MN
David B KaysenDirectorWaconia, MN
David B KaysenExecutive OfficerWaconia, MN
Michael T CullenDirectorWaconia, MN
Michael T CullenExecutive OfficerWaconia, MN
Suzanne X GagnonDirectorWaconia, MN
Suzanne X GagnonExecutive OfficerWaconia, MN
Donald R SchemelDirectorWaconia, MN
Daniel E RyweckExecutive OfficerWaconia, MN
Clifford F McCurdy, IIIDirectorPonte Vedra Beach, FL
Clifford F McCurdy, IIIExecutive OfficerPonte Vedra Beach, FL
Randall L JohnsonExecutive OfficerMinnetonka, MN
Douglas M PolinskyDirectorWayzata, MN
Douglas M PolinskyExecutive OfficerWayzata, MN
Ryan R GilbertsonExecutive OfficerDelano, MN
Christopher R JohnsonExecutive OfficerEden Prairie, MN
Paul M HerronDirectorPonte Vedra Beach, FL
Paul M HerronExecutive OfficerPonte Vedra Beach, FL

Other filings by this issuer (4)

FiledFormOfferingSold
2015-09-17D$1.2M$1.2M
2014-02-04D$6.0M$3.1M
2013-05-23D$2.0M$900K
2012-03-12D$2.0M$549K

More